ASX:ATX
AUD
0.054
- (-1.8%)
AMPLIA THERAPEUTICS LIMITED
Industry: Biotechnology
End of Day: 9 May 2025 GMT+10
AUD 0.054
- (-1.8%)
End of Day: 9 May 2025 GMT+10
Industry: Biotechnology
Quote
Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-
Company Info
more
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, w...
Key Ratios
more
Income
more
Total Revenues (AUD, MM)
-
Net Income (AUD, MM)
-
Net Margin
-
Balance Sheet
more
Total Assets (AUD, MM)
-
Total Liabilities (AUD, MM)
-
Book Value Per Share
-
Cash Flow
more
Operations (AUD, MM)
-
Investing (AUD, MM)
-
Financing (AUD, MM)
-
Make Smart Investment Choices